Literature DB >> 20671310

Identifying supportive and palliative care needs in people with a recent diagnosis of thoracic cancer: acceptability of the SPARC questionnaire.

Andrew Wilcock, Radka Klezlova, Sarah Coombes, Amanda Rawson, Rachel Bentley, Doug Hooper, Matthew Maddocks.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20671310     DOI: 10.1136/thx.2009.131243

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  5 in total

1.  Using patient-reported outcome measures to deliver enhanced supportive care to people with lung cancer: feasibility and acceptability of a nurse-led consultation model.

Authors:  Grigorios Kotronoulas; Constantina Papadopoulou; Mhairi F Simpson; John McPhelim; Lynn Mack; Roma Maguire
Journal:  Support Care Cancer       Date:  2018-05-19       Impact factor: 3.603

2.  Holistic needs assessment in advanced, intensively treated multiple myeloma patients.

Authors:  E G Boland; J W Boland; Y Ezaydi; D M Greenfield; S H Ahmedzai; J A Snowden
Journal:  Support Care Cancer       Date:  2014-04-15       Impact factor: 3.603

3.  Occupational therapy needs of patients with thoracic cancer at the time of diagnosis: findings of a dedicated rehabilitation service.

Authors:  Rachel Bentley; Asmah Hussain; Matthew Maddocks; Andrew Wilcock
Journal:  Support Care Cancer       Date:  2012-12-27       Impact factor: 3.603

4.  A Systematic Review of the Development and Implementation of Needs-Based Palliative Care Tools in Heart Failure and Chronic Respiratory Disease.

Authors:  Amy Waller; Breanne Hobden; Kristy Fakes; Katherine Clark
Journal:  Front Cardiovasc Med       Date:  2022-04-13

5.  Lung cancer diagnosed following emergency admission: a mixed methods study protocol to improve understanding of patients' characteristics, needs, experiences and outcomes.

Authors:  Andrew Wilcock; Vincent Crosby; Sarah Freer; Alison Freemantle; Glenys Caswell; Jane Seymour
Journal:  BMC Palliat Care       Date:  2013-05-28       Impact factor: 3.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.